The 16-Plex ProcartaPlex 1 human cytokine & chemokine panel allows the exploration of immune response by analyzing 16 protein targets in a single well using Luminex xMAP technology. The panel is composed of two...
The 16-Plex ProcartaPlex 1 human cytokine & chemokine panel allows the exploration of immune response by analyzing 16 protein targets in a single well using Luminex xMAP technology. The panel consists of two modular sub-panels that form a subset of the cytokine / chemokine / growth factor 45-Plex ProcartaPlex 1 panel (ref. EPX450-12171-901. This kit can be fully combined with other singlex panels or dosages corresponding to the targets in the 45-Plex panel.
ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. All ProcartaPlex panels are supplied with the reagents necessary to perform the dosage.
ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine).
Target list [microbead region]:
Inflammatory Cytokines: IFN alpha [48], IL-1 alpha [62], IL-1RA [38], IL-7 [26], IL-8 (CXCL8) [27], IL-15 [65], IL-31 [37], TNF beta [54]
Chemiokines: Eotaxin (CCL11) [33], GRO alpha (CXCL1) [61], IP-10 (CXCL10) [22], MCP-1 (CCL2) [51], MIP-1 alpha (CCL3) [12], MIP-1 beta (CCL4) [47], RANTES (CCL5) [42], SDF-1 alpha [13]
About ProcartaPlex strengths for Luminex platform
ProcartaPlex immunoassays are based on the principles of ELISA sandwich assay, using two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all protein targets using a Luminex instrument. ProcartaPlex multiplex assays require only 25 μl plasma or serum, or 50 μl cell culture supernatant, and only four hours to obtain the analyzed results.
• Reproducible and reliable results — validated in panel to the highest industry standard, with tests for protein target combinationability and cross-reactivity
• Plus of results per sampler — allows multiple protein targets to be achieved simultaneously in a single sample of 25 - 50 μl
• High-reference multiplexing platform with well established Luminex technology for protein detection and quantification
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) Technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 μl sample — plasma, serum, cell culture supernatant and other body fluids.
Luminex microbeads in the ProcartaPlex assay are coloured internally with precise proportions of red fluorophores and IR to create unique spectral signatures that can be identified by Luminex xMAP detection systems (e.g. Luminex 200, FLEXMAP 3D and MAGPIX). Like ELISA sandwich, the ProcartaPlex assay uses paired antibody pairs to identify the protein of interest. In a multiplexed assay, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). Conjugation of specific antibodies from a protein to a separate microbead makes it possible to analyze several targets in a single well.
The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is conjugated with a microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.